The influence of peripherally administered adrenaline on the secretion of human growth hormone (HGH) and cortisol was investigated in 14 normal subjects. In a control group, HGH and cortisol release was stimulated by insulin infusion for 30 min (0.1 IU/kg). This procedure was compared with a similar insulin infusion which was started 60 min after initiating an adrenaline infusion for 150 min (6 \g=m\g/min). Adrenaline did not significantly alter the basal levels of HGH and cortisol. The mean maximal HGH rise during insulin hypoglycaemia (38.9 \ m=+-\ 7.2 ng/ml) was significantly (P < 0.005) inhibited by simultaneously administered adrenaline (9.6 \ m=+-\3.0 ng/ml). The same action of adrenaline was also found to be effective on cortisol release. The rise in plasma cortisol after insulin infusion (16.0\m=+-\1.4\g=m\g/100ml) was suppressed by adrenaline to 6.4 \ m=+-\ 2.2\g=m\g/100 ml (P < 0.005). Blood glucose and plasma free fatty acids (FFA), increased by adrenaline administration, were decreased significantly after insulin infusion. These results suggest an inhibitory effect of peripheral adrenaline on insulin-induced secretion of HGH.
It is well established that insulin-induced hypoglycaemia is a potent stimulus for growth hormone and cortisol release in man (Bliss et al. 1954; Landon et al. 1963; (Roth el al. 1963 ; Baylis et al. 1968 ) to a greater degree than the release of cortisol (Baylis et al. 1968 ). The decrease in plasma FFA mediated by the action of insulin is another stimulus which can induce a somatotrophic response (Irte et 0, 5, 10, 15, 20, 25, 30, 35, 40, 45, 50, 55, 60, 75, 90 and 120 min for the determination of blood glucose; at 0, 10, 20, 30, 40, 50, 60, 75, 90 and 120 min for plasma insulin (IRI); and at 0, 15, 30, 45, 60, 75, 90 and 120 min for plasma FFA, HGH and cortisol. Urine samples were collected before and after the test for the determination of adrenaline and noradrenaline.
In the second test (b), adrenaline (adrenaline hydrochloride, 900 /«g diluted in 500 ml of saline with the addition of 2.5 mg/ml of ascorbic acid to prevent oxidation) was infused at a constant rate of 6 /<g/min for 150 min (-60 to 90 min in the test schedule).
From minutes 0 to 30 insulin was infused in the same manner as described above.
Blood samples were taken at -60, -45, -30, -15, 0, 15, 30, 45, 60, 75, 90, 105 and 120 min for the determination of blood glucose and plasma IRI; at -60, 0, 30, 60, 90 and 120 min for plasma FFA; 0, 30, 45, 60, 90 Mattingly (1962) , and plasma FFA according to Duncombe (1963 (b) Adrenaline infusion was followed by hyperglycaemia: 149.5 ± 8.1 mg/100 ml. After insulin, the blood glucose began to decrease but with a greater delay (15 vs. 5 min). The minimum of 93.9 ± 10.0 mg/100 ml occurred at 60 min (63°/ o of the 0-minute level). Glycaemia increased again until the end of the adrenaline infusion and decreased thereafter. All values were significantly lower than the 0-minute level.
4. Plasma FFA (Fig. 3) (a) Insulin caused a significant decrease to 0.38 + 0.08 mEq./lOOO ml at 30 min; after this, the FFA increased to 0.90 ± 0.09 mEq./lOOO ml at 120 min. which was significantly higher than the basal value. The effects of insulin and adrenaline + insulin on plasma immunoreactive insulin levels (mean ± sem). The 30-min insulin infusion (0.1 IU/kg) is indicated by the dotted area, the curve in this condition by a solid line (control group). Adrenaline infusion (6 «g/min) in the second group was started 60 min before initiating the insulin infusion and was continued until 90 min thereafter (broken line). Statistical signficance against basal value (start of insulin infusion) is indicated by a black star (P < 0.05, paired data), the significance between the 2 curves by white stars (P < 0.05, unpaired data).
(b) With adrenaline, FFA increased to 1.16 ± 0.13 mEq./lOOO ml. Admin¬ istration of insulin lowered this level within 30 min to 0.42 ± 0.04 mEq./lOOO ml.
Significant differences between both testes were found at 0 and at 120 min.
5. Plasma HGH (Fig. 4) (a) After insulin only, HGH concentration increased from 0.2 ±0.1 to 36.7 ± 7.4 ng/ml at 75 min. The HGH response was first detectable at 45 min. HGH levels were significantly higher than the basal level at 60, 75, 90 and 120 min.
(b) Adrenaline caused no significant rise in the basal HGH levels. After the addition of insulin, they increased to 9.8 ± 3.1 ng/ml at 60 min. The HGH values after adrenaline + insulin were significantly higher than after insulin alone at 0 min (both within the normal range) and 30 min but significantly lower at 60 and 90 min.
6. Plasma cortisol (Fig. 5) (a) In the control test, the cortisol levels increased to 31.0 ± 1.1 /¿g/100 ml at 75 min. The values were significantly higher than the basal level at 45, 60 75 and 90 min. The increase in blood glucose and FFA levels after adrenaline could be the reason for the lack of an HGH increase under these conditions. Hyperglycaemia can lower the HGH levels in acromegalie patients (Roth et al. 1963) and suppress the HGH increase after exercise (Hansen 1971 ) and arginine infusion (Burday et al. 1968 ). High FFA levels produced by lipid administra¬ tion inhibit the stimulation of HGH secretion to insulin-induced hypoglycaemia (Blackard et al. 1971; Quabbe et al. 1972 ).
Another reason for the lack of HGH secretion after adrenaline could be the fact that this hormone has an inhibitory rather than a stimulating effect, contrary to the supposition of Blackard 8c eidingsfehler (1968) . This concept is supported by our results which demonstrate an inhibitory effect of exogenous adrenaline on insulin-induced HGH secretion. The mean maximal increase in HGH in our experiments was 38.9 ± 7.2 ng/ml without and 9.6 ± 3.0 ng/ml with adrenaline (P < 0.005 (1972) demonstrated that peripheral adminis¬ tration of adrenaline has a stimulating effect on HGH secretion during the administration of a /^-adrenergic receptor blocking agent.
There is little doubt that catecholamines, mainly noradrenaline and dopamine, participate in the regulation of the function of the anterior pituitary gland. They are particularly concentrated in those regions of the brain, which are known to be involved in this control, e. g. the hypothalamus and midbrain (Wurtman 1970 ). However, it seems that there are species differences regarding these regulating processes since the elevation of peripheral catecholamine concentration in monkeys (Meyer 8c Knobil 1967) and rats (Müller et 2. or it stimulates by means of ß-adrenergic mechanisms the release of a growth hormone inhibiting factor (GIF), which was described for the first time by Krulich et al. (1968) (Yalow et al. 1969) .
In summary, our results demonstrate an important role of adrenaline in the secretion of cortisol as well as in the release of growth hormone in man. Whether its inhibitory action is mediated by a negative feedback mechanism between adrenaline and respectively ACTH and HGH has yet to be clarified.
